NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi

Go back to NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi
(NASDAQ: NTHI) Delayed: 2.92 +0.15 (5.42%)
Previous Close $2.77    52 Week High $ 
Open $2.80    52 Week Low $ 
Day High $2.92    P/E N/A 
Day Low $2.75    EPS $ 
Volume 47,028